Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1878050

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1878050

Pharmaceutical Glycerine Market Size, Share, and Growth Analysis, By Type (99.7% Purity, Above 99.7% Purity), By Source (Animal, Plant), By Application, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Pharmaceutical Glycerine Market size was valued at USD 38.5 million in 2024 and is poised to grow from USD 41.08 million in 2025 to USD 69.01 million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is witnessing significant growth driven by its expanding applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. The rising demand for cough syrups, wound care ointments, and glycerine-based capsules in emerging markets is fueling consumption. This growth is also bolstered by advancements in the pharmaceutical sector, particularly in the Asia-Pacific and Latin America regions, alongside improvements in manufacturing processes that yield higher purity glycerine. The increasing preference for plant-derived glycerine is further supporting the shift towards sustainable bio-based materials. However, challenges such as raw material supply fluctuations, production costs due to regulatory compliance, and disruptions in the palm oil and soybean oil markets may impact pricing and availability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

One of the key market drivers for the global pharmaceutical glycerine market is the rising demand for natural and organic ingredients in drug formulations. As the pharmaceutical industry increasingly focuses on sustainability and consumer preferences for eco-friendly products, glycerine, derived from renewable sources, is gaining traction for its diverse applications in medicines, excipients, and antifreeze formulations. Additionally, glycerine's multifunctional properties, such as being an effective humectant, solvent, and sweetening agent, make it an essential component in the development of various pharmaceutical products, further boosting its utilization and driving market growth.

Restraints in the Global Pharmaceutical Glycerine Market

One key market restraint for the Global Pharmaceutical Glycerine Market is the stringent regulatory environment governing the production and use of glycerine in pharmaceuticals. Compliance with varied international quality standards and regulations can pose significant challenges for manufacturers, leading to increased costs and longer development timelines. Additionally, the potential for contamination and the need for consistent product purity can limit production capabilities. These regulatory hurdles can deter small and medium-sized enterprises from entering the market, thus reducing overall competition and innovation, ultimately hindering market growth and expansion.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is witnessing a significant shift towards plant-based glycerine, fueled by increasing consumer demand for sustainable and vegan-friendly products. This trend reflects a broader commitment to ethical sourcing and clean-label initiatives, as companies prioritize transparency and environmental responsibility in their formulations. The rise of regulatory standards favoring sustainable ingredients further amplifies this movement, particularly in key regions like Europe and North America, where the adoption of natural excipients is rapidly gaining momentum. As awareness of the benefits of plant-derived alternatives continues to grow, the market is expected to expand, leading to innovative applications and formulations.

Product Code: SQMIG35I2481

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • 99.7% Purity
  • Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

  • Market Overview
  • Animal
  • Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Oral Use
  • External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

  • North America (Type, Source, Application)
    • US
    • Canada
  • Europe (Type, Source, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Source, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Source, Application)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Source, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • IOI Oleo GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Archer Daniels Midland Company (ADM) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • KLK Oleo (Malaysia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oleon NV (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dow, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cargill, Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emery Oleochemicals (Malaysia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • P&G Chemicals (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wilmar International Limited (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Chemical Company (TCC) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Godrej Industries Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Twin Rivers Technologies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VVF LLC (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avril Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GLACONCHEMIE GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croda International Plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rajaram Solvents Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3F Chimica SpA (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solvay SA (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peter Greven GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!